The National Pharmaceutical Pricing Authority (NPPA) has announced revised maximum retail prices (MRPs) for 543 brands of anti-cancer medicines. The new prices will come into effect on November 9, 2026, according to information released by the authority. The list will be updated regularly as additional revised prices are received from manufacturers.
The revised price list has been issued under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers. It includes information submitted by pharmaceutical companies up to October 27, 2026. The NPPA will incorporate further updates as manufacturers provide revised prices for non-scheduled anti-cancer medicines.
NPPA Revises Prices of Nine Cancer Medicines
The updated list includes substantial price reductions for several medicines used in cancer treatment. The revised MRPs cover products manufactured by companies including RPG Life Sciences, Dr. Reddy’s Laboratories, Abbott Healthcare, Natco Pharma, Neon Laboratories and Hetero Healthcare.
Some of the key price changes listed in the supplied information are detailed below.
| Manufacturer | Medicine | Brand name as provided | Previous MRP | Revised MRP |
|---|---|---|---|---|
| RPG Life Sciences Ltd | Anastrozole | Energol | ₹695.76 | ₹73.00 |
| Dr. Reddy’s Laboratories Ltd | Azacitidine | Azacetin | ₹6,337.00 | ₹1,495.04 |
| Abbott Healthcare Pvt. Ltd | Bevacizumab | “stupid”* | ₹21,767.70 | ₹5,930.13 |
| Natco Pharma Ltd | Dasatinib | Dasnat 20 | ₹2,812.50 | ₹1,085.93 |
| RPG Life Sciences Ltd | Denosumab | Dabrumab 60 mg | ₹22,031.25 | ₹5,941.00 |
| RPG Life Sciences Ltd | Enzalutamide | Annut | ₹6,578.20 | ₹2,232.00 |
| Neon Laboratories Ltd | Erlotinib | Erlib | ₹4,637.45 | ₹2,008.00 |
| Hetero Healthcare Ltd | Fludarabine | Fludanox | ₹14,235.00 | ₹2,432.00 |
| RPG Life Sciences Ltd | Fulvestrant | Fulbric | ₹26,072.16 | ₹5,491.00 |
The brand name provided for Abbott Healthcare’s bevacizumab is listed as “stupid” in the source material and requires verification against the official NPPA list before publication.
New Prices to Take Effect on November 9, 2026
The revised rates represent significant reductions in the listed MRPs of the medicines covered in the announcement. The changes apply from November 9, 2026, while the authority continues to update its list as further manufacturer information becomes available.
The figures above are reproduced from the supplied article. Brand names, pack sizes and individual prices should be checked against the official NPPA notification to ensure accuracy before publication or use for purchasing decisions.
Disclaimer: This article is intended for general informational purposes only and is based on the information provided in the source material. The listed prices and brand names have not been independently verified here. Readers should consult the latest official NPPA price list or contact the relevant manufacturer or pharmacist to confirm the applicable MRP, product details and effective date.